ArticleJournal of diabetes research2021

Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction.

Kunimasa Yagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.